Founded by former NCI researchers, BioServe Biotechnologies,Ltd. specializes in custom laboratory services, biomedical research, and the development of diagnostic reagents. The company's team of experienced professionals include molecular biology specialists, laboratory technicians, and support personnel. Bio-Serve provides a comprehensive 'biomaterial to validated data' genomics services platform, helping researchers gain the pre-clinical data for breakthroughs in drug discovery, molecular diagnostics and pharmacogenomics. Utilizing BioServe's genomics services platform, researchers can identify genetic markers, validate drug targets and correlate clinical data with molecular data to accelerate the development of new and safer drugs. BioServe's services extend from nucleic acids processing, DNA synthesis, high throughput genotyping, genome wide-scans and gene expression analyses to ready-made large epidemiologically sound case-control studies of inflammatory disorders, endocrine disorders, cardiovascular disease, diabetes, hypertension, obesity and many cancers. BioServe's Global BioRepository provides researchers with a library of 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients from four continents, In 2002, the US parent established BioServe-India: the first company to provide DNA synthesis, DNA sequencing, and related services in India. In addition to the type of services offered by the parent firm, services at BioServe-India include Food Pathogen Testing and testing for Genetically Modified Organisms in finished products. BioServe-India is a DSIR recognized laboratory with ISO9001-2008 and NABL accreditation. BioServe-Indiaâs customers include nearly every ICMR and CSIR institute and several major pharmaceutical and biotechnology companies, as well as top industry and academic researchers. In August 2014, BioServe-India was acquired by Cancer Genetics. In 2007, BioServe had acquired assets of Genomics Collaborative, Inc. from SeraCare - both of which entities were previously SBIR involve
